Geriatrics & Aging

Season Vildan Professor in Department of Family Medicine Science Department of Internal Medicine Dokuz Eylul University

Healthy ageing, management of hypertension and diabetes in primary care, smoking cessation, E-health in primary care, evidence-based medicine, clinical decision-making

In 1986 he was appointed CEO of the Deutscher Paritätischer Wohlfahrtsverband Berlin (dpw), a major umbrella welfare organisation. Starting in 1992, he set up a non-profit healthcare company for the dpw with several hospitals, polyclinics, nursing homes – an organisation with nearly 4,000 employees and a turnover of approx. 200 million €. He retired in 2003 and started working as consultant.

Telemedicine services in regular healthcare and especially for elderly persons.

Robbert Gobbens InHolland Hogeschool Netherlands

Nursing Practice

EMAAD M. O. ABDEL-RAHMAN did M.D, Ph.D and he is a FASN Professor in Division of Nephrology in Department of Internal Medicine, UVA and He is member of American Society of Nephrology, International Society of Nephrology, National Kidney Foundation, Renal Physician Association, Medical Society of Virginia, American Heart Association-Kidney Council, Egyptian Society of Nephrology, Egyptian Medical Council and he written more than 45 papers and written many books on Geriatric Nephrology and Nephrology

GERIATRIC NEPHROLOGY: As director of hemodialysis unit and head of Geriatric Nephrology section, improving the longevity as well as the quality of life in elderly patient on hemodialysis has been my major concern. Over the past 2 years, I published 11 manuscripts, 2 book chapters as well as being a contributor in preparing the first curriculum on Geriatric Nephrology that is published on the American Society of Nephrology website. Trying to understand, better diagnose and manage such problems as depression, falls, and frailty that are common in elderly population on dialysis has been the focus of my research. AKI: As director of the newly formed Therapeutic extracorporeal care Unit (TECU), improving and predicting the outcome of dialysis-dependent hemodialysis (D-AKI) patients has been crucial. Two studies were launched, one trying to evaluate clinical predictors of outcome of D-AKI and the other evaluating biomarkers as predictors of outcome in D-AKI patients.